This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_RECTUM_SQUAM_EXALLC for full statistics.
Squamous cell neoplasms and carcinoma of rectum
C3_RECTUM_SQUAM
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
37 |
4. Check minimum number of eventsNone |
37 |
5. Include endpointsNone |
37 |
6. Filter based on genotype QC (FinnGen only) |
37 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Squamous cell neoplasms and carcinoma of rectum
based on the number of shared cases.
Similar with more cases:
- Squamous cell neoplasms and carcinoma of rectum, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of rectum
- Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)
- Colorectal cancer
- Colorectal cancer, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 37 | 30 | 7 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | 62.27 | 60.13 | 71.42 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022145) Colonoscopy Study observation
24
35
17.67
18.18
2.8
1.1
—
—
—
0
0
(4035726)
17
27
10.80
11.41
1.4
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
28
138
5.21
4.92
9.1
5.5
g/l
35.7
35.1
0.34
28
130
(3012095) Magnesium [Moles/volume] in Serum or Plasma
16
53
4.56
4.65
2.0
2.8
mmol/l
0.8
0.8
0.67
16
48
(3023368) Bacteria identified in Blood by Culture
19
75
4.15
4.33
6.0
4.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
27
138
4.54
4.27
3.6
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
22
112
3.38
3.20
8.4
4.6
mmol/l
2.3
2.3
0.30
22
96
(40758558) Short blood count panel - Blood
18
83
3.28
3.05
10.1
9.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
7
14
5.89
2.88
6.1
5.5
mmol/l
24.7
25.8
—
7
14
(3002256) Pathology report gross observation
11
41
3.39
2.54
2.0
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
13
54
3.17
2.54
2.5
2.8
e6/l
2.7
4.2
—
7
29
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
8
23
4.14
2.43
1.0
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
15
70
2.92
2.39
2.4
2.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
20
110
2.78
2.35
3.7
3.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
6
15
4.55
2.13
1.0
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
16
83
2.63
2.05
3.4
3.9
%
101.1
93.2
0.53
16
83
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
28
197
2.73
2.04
10.2
7.6
umol/l
7.9
9.9
2.39
28
184
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
5
11
5.06
2.01
6.0
9.9
%
0.4
0.8
—
5
11
(3014007) Fractional oxyhemoglobin in Arterial blood
5
11
5.06
2.01
6.0
10.3
%
97.4
94.7
—
5
11
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
5
11
5.06
2.01
6.0
9.9
%
0.9
1.4
—
5
11
(3037467) Urinalysis macro (dipstick) panel - Urine
29
211
2.73
1.87
5.4
4.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
17
95
2.46
1.83
3.7
3.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
22
139
2.44
1.81
5.8
4.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
14
3.95
1.67
1.0
1.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
12
59
2.53
1.66
5.0
4.0
mmol/l
2.5
2.5
0.19
12
48
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
13
68
2.41
1.58
1.9
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
16
93
2.27
1.53
2.9
2.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
16
3.44
1.49
9.4
9.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
19
120
2.20
1.48
2.2
1.9
pmol/l
87.1
98.3
—
10
50
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
12
63
2.34
1.43
2.1
2.6
e6/l
0.2
1.0
—
6
38
(42870588) Differential panel, method unspecified - Blood
17
104
2.17
1.42
5.0
5.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
22
150
2.15
1.39
3.4
5.9
e9/l
0.5
0.6
0.34
16
137
(3006315) Basophils [#/volume] in Blood
22
150
2.15
1.39
3.4
6.0
e9/l
0.0
0.0
2.81
16
137
(3032080) INR in Blood by Coagulation assay
19
123
2.12
1.37
5.3
6.9
inr
1.0
1.2
—
5
39
(3021589) Normoblasts [#/volume] in Blood
19
124
2.09
1.33
17.2
10.8
e9/l
0.0
0.0
0.00
13
99
(3002173) Hemoglobin [Mass/volume] in Arterial blood
6
25
2.66
1.30
8.3
8.0
g/l
112.7
119.0
—
6
25
(3019198) Lymphocytes [#/volume] in Blood
22
153
2.08
1.29
3.7
6.0
e9/l
1.3
1.8
2.50
17
141
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
19
2.88
1.26
1.6
2.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
5
19
2.88
1.26
6.4
8.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
7
30
2.64
1.20
1.3
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
22
157
1.99
1.16
4.2
5.9
e9/l
0.1
0.2
1.47
17
143
(3048689) Calprotectin [Mass/mass] in Stool
7
32
2.46
1.15
1.3
1.6
ug/g
92.9
94.2
—
7
25
(46235355) HIV 1 and 2 tests - Meaningful Use set
7
33
2.38
1.13
1.1
1.6
—
—
—
0
0
(3000492) Spirometry study
5
21
2.59
1.13
1.0
1.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
6
27
2.45
0.99
8.3
7.6
%
98.3
95.6
—
6
27
(36660697) Celiac disease serology panel - Serum
0
27
0.00
0.81
0.0
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
15
104
1.74
0.79
4.9
2.6
u/l
59.5
55.3
0.21
15
95
(3003694) ABO and Rh group [Type] in Blood
11
70
1.81
0.76
1.3
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
5
26
2.06
0.73
1.0
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
26
299
0.56
0.72
3.7
5.8
mmol/mol
36.7
39.9
2.05
21
277
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
27
1.98
0.71
1.4
2.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7
44
1.73
0.69
1.7
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
7
44
1.73
0.69
1.7
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
9
60
1.66
0.61
5.0
5.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
29
257
1.59
0.46
33.6
18.6
%
13.8
13.7
0.13
29
252
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
8
57
1.51
0.46
2.4
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
9
65
1.51
0.43
1.4
1.7
mg/l
3.6
0.8
—
9
56
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
16
0.00
0.42
0.0
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
32
293
1.68
0.41
23.0
15.5
%
37.7
39.6
1.40
25
211
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
18
0.00
0.41
0.0
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
20
172
1.35
0.32
2.8
2.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
30
314
0.76
0.32
3.7
4.7
mmol/l
5.7
5.8
0.46
25
289
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
28
296
0.78
0.28
4.7
4.8
mu/l
2.0
1.9
0.24
23
267
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
12
98
1.33
0.25
1.3
2.1
u/l
96.0
113.9
0.21
12
93
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
14
118
1.30
0.24
2.6
3.5
u/l
24.1
30.0
0.87
14
110
(40768443) Skin Pathology biopsy report
0
11
0.00
0.22
0.0
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
0
11
0.00
0.22
0.0
1.7
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
0
10
0.00
0.22
0.0
4.4
—
24.6
—
0
10
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
10
0.00
0.22
0.0
1.8
—
93.3
—
0
10
(3022313) Gas panel - Capillary blood
0
10
0.00
0.22
0.0
4.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
10
0.00
0.22
0.0
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
0
10
0.00
0.22
0.0
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
0
10
0.00
0.22
0.0
2.6
—
—
—
0
0
(3020891) Body temperature
0
10
0.00
0.22
0.0
4.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
9
104
0.82
0.15
4.7
2.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
10
85
1.24
0.14
4.2
3.6
—
—
—
0
0
(3015736) pH of Urine
10
113
0.84
0.10
2.6
3.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
19
177
1.15
0.09
6.6
4.5
mmol/l
6.3
6.5
0.38
19
167
(3011397) Hemoglobin [Presence] in Urine by Test strip
6
69
0.84
0.08
2.7
3.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
9
102
0.84
0.07
2.0
3.0
—
—
—
0
0
(3013512) EKG study
10
90
1.15
0.06
3.4
3.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
12
129
0.90
0.04
2.6
2.3
nmol/l
74.7
75.8
0.05
12
115
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
12
114
1.08
0.01
3.7
3.9
—
—
—
0
0
(3044889) 12 lead EKG panel
23
234
0.95
0.00
4.1
3.9
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
283.2
—
0
6
(3026493) Urate [Moles/volume] in Serum or Plasma
8
79
1.02
0.00
1.4
2.4
umol/l
30991.3
6724.3
—
8
64
(3051651) Icteric interference index of Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1002224) Polysomnography panel
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
6
58
1.04
0.00
1.7
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
2.5
—
0
8
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
5.5
—
0
6
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
6
63
0.94
0.00
1.3
1.4
g/l
2.0
2.3
—
6
32
(3026389) Candida sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
0
7
0.00
-0.00
0.0
4.7
—
1.8
—
0
7
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
7
0.00
-0.00
0.0
3.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_RECTUM_SQUAM – Squamous cell neoplasms and carcinoma of rectum
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).